The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed ...
In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro talks about the challenges faced in developing T cell engagers.
James Foster, CEO and co-founder of Virax Biolabs, discusses how AI and machine-learning algorithms are changing the ways that companies approach their launch strategies.
Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...
As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...
Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...
Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...
In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies ...
Robert F. Kennedy Jr. will serve as Secretary of Health and Human Services. 1 The US Senate voted 52-48 in favor of Kennedy ...
Artificial intelligence (AI) and machine learning have transformed this landscape by enabling complex, predictive alerts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results